{{Rsnum
|rsid=676210
|Gene=APOB
|Chromosome=2
|position=21008652
|Orientation=plus
|GMAF=0.3379
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=APOB
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 28.3 | 65.5
| HCB | 49.3 | 42.6 | 8.1
| JPT | 50.0 | 41.1 | 8.9
| YRI | 3.4 | 22.4 | 74.1
| ASW | 0.0 | 38.6 | 61.4
| CHB | 49.3 | 42.6 | 8.1
| CHD | 61.7 | 27.1 | 11.2
| GIH | 27.7 | 49.5 | 22.8
| LWK | 0.9 | 24.5 | 74.5
| MEX | 3.4 | 37.9 | 58.6
| MKK | 2.6 | 14.7 | 82.7
| TSI | 6.9 | 36.3 | 56.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20724655
|Title=ApoB genetic variants modify the response to fenofibrate: a GOLDN study
|OA=1
}}

{{PMID Auto
|PMID=18296645
|Title=Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.
|OA=1
}}

{{PMID Auto
|PMID=19474294
|Title=Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.
|OA=1
}}

{{PMID Auto
|PMID=19936222
|Title=Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.
|OA=1
}}

{{GET Evidence
|gene=APOB
|aa_change=Pro2739Leu
|aa_change_short=P2739L
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs676210
|overall_frequency_n=2124
|overall_frequency_d=10758
|overall_frequency=0.197434
|n_genomes=18
|n_genomes_annotated=0
|n_haplomes=23
|n_articles=0
|n_articles_annotated=0
|qualityscore_in_silico=2
|qualitycomment_in_silico=Y
|gene_in_genetests=Y
|genetests_testable=Y
|nblosum100=7
|autoscore=2
|n_web_uneval=5
}}

{{PMID Auto
|PMID=23247145
|Title=Genome-Wide Association Study Pinpoints a New Functional ApoB Variant Influencing Oxidized LDL Levels but Not Cardiovascular Events: AtheroRemo Consortium
}}

{{PMID Auto
|PMID=22715478
|Title=Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}